Skye Bioscience Ratios (2012-2014) | SKYE

Ratios Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jun2014 Dec2014
Profitability
Gross Margin 82.81%80.17%79.07%79.70%77.45%77.19%
EBT Margin 0.42%2.87%-1.65%-6.65%5.71%-18.55%
EBIT Margin -10.84%3.32%0.82%-6.37%-1.94%-18.44%
EBITDA Margin -10.84%3.32%5.04%-6.37%-1.94%-18.44%
Operating Margin -10.84%3.32%0.82%-6.37%-1.94%-18.44%
Net Margin 0.28%1.90%-0.78%-6.65%5.71%-18.55%
FCF Margin -104.95%-82.80%-90.88%-10.57%-6.54%4.55%
Efficiency
Assets Average 131,679.50137,342.50143,265.00131,782.00
Equity Average 65,167.0074,061.5085,187.0080,189.00
Invested Capital 38,559.0065,588.0064,746.0083,377.0086,997.0073,381.00
Asset Utilization Ratio 1.952.482.422.35
Leverage & Solvency
Interest Coverage Ratio -29.085.571.12-8.40-3.00-43.75
Debt to Equity 0.24
Debt Ratio 0.12
Equity Ratio 0.900.490.500.570.620.60
Times Interest Earned -29.085.571.12-8.40-3.00-43.75
Valuation
Enterprise Value -13082.00-26404.00-23261.00-29712.00-37151.00-52186.00-46476.00-49952.00-528494.00
Return Ratios
Return on Sales 0.00%0.02%-0.01%-0.07%0.06%-0.19%-0.72%-21.15%
Return on Capital Employed -0.09%-0.02%-0.23%
Return on Assets 0.05%-0.03%0.00%-0.12%
Return on Equity 0.10%-0.05%-0.01%-0.20%